Global Infectious Disease Diagnostics Supply, Demand and Key Producers, 2026-2032
The global Infectious Disease Diagnostics market size is expected to reach $ 36133 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032).
Infectious Disease Diagnostics refers to a system of in-vitro diagnostic reagents, instruments, automated platforms, informatics systems, and quality-control solutions used to detect, identify, type, quantify, and clinically interpret pathogens or infection-related markers in human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. It targets infectious diseases caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens, and may detect nucleic acids, antigens, antibodies, toxins, resistance genes, or host immune-response markers. The field covers molecular diagnostics, immunodiagnostics, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, point-of-care testing, multiplex panels, and sequencing. It is widely used in clinical diagnosis, infection control, antimicrobial stewardship, public health surveillance, border quarantine, and epidemic early warning, supporting early detection, diagnosis, isolation, treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostics is evolving from single-outbreak emergency demand into a long-term sector jointly driven by clinical care, public health security, and healthcare-system resilience. Emerging infectious diseases, seasonal respiratory outbreaks, chronic viral infection management, tuberculosis and antimicrobial resistance control, hospital-acquired infection monitoring, and rational antimicrobial use are all driving continuous investment in rapid, precise, and traceable testing capabilities across healthcare institutions and public health systems. Government documents continue to strengthen disease control systems, medical-public health coordination, and interconnection of pathogen testing data, while corporate annual reports show that global diagnostic leaders regard infectious disease testing as an important strategic direction across molecular diagnostics, immunodiagnostics, and microbiology. Multi-platform integration, multiplex pathogen testing, automated workflows, and data-driven surveillance will continue to expand the value boundary of the industry.The infectious disease diagnostics industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, healthcare cost control, and product homogenization. After the pandemic, demand for certain single-pathogen tests has normalized, requiring companies to shift from short-cycle outbreak-driven products toward multi-scenario portfolios covering respiratory, blood-borne, gastrointestinal, reproductive tract, hospital-acquired infection, and antimicrobial resistance monitoring. Molecular diagnostics require high sensitivity, specificity, contamination control, and laboratory workflow capability. Immunodiagnostics emphasize antigen and antibody quality as well as lot-to-lot consistency, while microbiological diagnostics depend on sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. Future competition will not be limited to product pricing, but will depend on clinical evidence, test menus, platform compatibility, channel services, quality systems, and supply-chain resilience.Downstream demand is shifting from ?whether testing is available? to ?rapid differentiation, precise typing, medication guidance, and data reporting.? Large hospitals increasingly emphasize coordination among emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams, using rapid etiological testing and resistance monitoring to shorten diagnostic time, optimize anti-infective therapy, and reduce nosocomial transmission risk. Primary healthcare institutions need tests that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems emphasize pathogen-spectrum monitoring, regional epidemic trend assessment, and early warning. As medical-public health collaboration and infectious disease surveillance systems improve, infectious disease diagnostics will become a key infrastructure linking clinical treatment efficiency, hospital operational quality, and public health governance.
This report studies the global Infectious Disease Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infectious Disease Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Disease Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infectious Disease Diagnostics total market, 2021-2032, (USD Million)
Global Infectious Disease Diagnostics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Infectious Disease Diagnostics total market, key domestic companies, and share, (USD Million)
Global Infectious Disease Diagnostics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Infectious Disease Diagnostics total market by Type, CAGR, 2021-2032, (USD Million)
Global Infectious Disease Diagnostics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Infectious Disease Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Danaher, Abbott, bioM?rieux, Hologic, Thermo Fisher Scientific, Roche, DiaSorin, QuidelOrtho, Siemens Healthineers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Infectious Disease Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Infectious Disease Diagnostics Market, By Region:
1. How big is the global Infectious Disease Diagnostics market?
2. What is the demand of the global Infectious Disease Diagnostics market?
3. What is the year over year growth of the global Infectious Disease Diagnostics market?
4. What is the total value of the global Infectious Disease Diagnostics market?
5. Who are the Major Players in the global Infectious Disease Diagnostics market?
6. What are the growth factors driving the market demand?
Infectious Disease Diagnostics refers to a system of in-vitro diagnostic reagents, instruments, automated platforms, informatics systems, and quality-control solutions used to detect, identify, type, quantify, and clinically interpret pathogens or infection-related markers in human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. It targets infectious diseases caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens, and may detect nucleic acids, antigens, antibodies, toxins, resistance genes, or host immune-response markers. The field covers molecular diagnostics, immunodiagnostics, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, point-of-care testing, multiplex panels, and sequencing. It is widely used in clinical diagnosis, infection control, antimicrobial stewardship, public health surveillance, border quarantine, and epidemic early warning, supporting early detection, diagnosis, isolation, treatment, and precise prevention.The average gross profit margin of this product is 53%.
Infectious disease diagnostics is evolving from single-outbreak emergency demand into a long-term sector jointly driven by clinical care, public health security, and healthcare-system resilience. Emerging infectious diseases, seasonal respiratory outbreaks, chronic viral infection management, tuberculosis and antimicrobial resistance control, hospital-acquired infection monitoring, and rational antimicrobial use are all driving continuous investment in rapid, precise, and traceable testing capabilities across healthcare institutions and public health systems. Government documents continue to strengthen disease control systems, medical-public health coordination, and interconnection of pathogen testing data, while corporate annual reports show that global diagnostic leaders regard infectious disease testing as an important strategic direction across molecular diagnostics, immunodiagnostics, and microbiology. Multi-platform integration, multiplex pathogen testing, automated workflows, and data-driven surveillance will continue to expand the value boundary of the industry.The infectious disease diagnostics industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, healthcare cost control, and product homogenization. After the pandemic, demand for certain single-pathogen tests has normalized, requiring companies to shift from short-cycle outbreak-driven products toward multi-scenario portfolios covering respiratory, blood-borne, gastrointestinal, reproductive tract, hospital-acquired infection, and antimicrobial resistance monitoring. Molecular diagnostics require high sensitivity, specificity, contamination control, and laboratory workflow capability. Immunodiagnostics emphasize antigen and antibody quality as well as lot-to-lot consistency, while microbiological diagnostics depend on sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. Future competition will not be limited to product pricing, but will depend on clinical evidence, test menus, platform compatibility, channel services, quality systems, and supply-chain resilience.Downstream demand is shifting from ?whether testing is available? to ?rapid differentiation, precise typing, medication guidance, and data reporting.? Large hospitals increasingly emphasize coordination among emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams, using rapid etiological testing and resistance monitoring to shorten diagnostic time, optimize anti-infective therapy, and reduce nosocomial transmission risk. Primary healthcare institutions need tests that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems emphasize pathogen-spectrum monitoring, regional epidemic trend assessment, and early warning. As medical-public health collaboration and infectious disease surveillance systems improve, infectious disease diagnostics will become a key infrastructure linking clinical treatment efficiency, hospital operational quality, and public health governance.
This report studies the global Infectious Disease Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infectious Disease Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Disease Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infectious Disease Diagnostics total market, 2021-2032, (USD Million)
Global Infectious Disease Diagnostics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Infectious Disease Diagnostics total market, key domestic companies, and share, (USD Million)
Global Infectious Disease Diagnostics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Infectious Disease Diagnostics total market by Type, CAGR, 2021-2032, (USD Million)
Global Infectious Disease Diagnostics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Infectious Disease Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Danaher, Abbott, bioM?rieux, Hologic, Thermo Fisher Scientific, Roche, DiaSorin, QuidelOrtho, Siemens Healthineers, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Infectious Disease Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Infectious Disease Diagnostics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Sample
- Respiratory Sample
- Urine Sample
- Other
- Molecular Diagnostics
- Immunodiagnostics
- Culture & AST
- POCT Rapid Tests
- Other
- Respiratory Infections
- Hepatitis & Blood-borne
- Sexually Transmitted Infections
- Gastrointestinal Infections
- Other
- Public Hospitals
- Third-party Independent Laboratory
- Other
- BD
- Danaher
- Abbott
- bioM?rieux
- Hologic
- Thermo Fisher Scientific
- Roche
- DiaSorin
- QuidelOrtho
- Siemens Healthineers
- Qiagen
- Bio-Rad
- Wondfo Biotech
- Autobio
- Daan Gene
- Innovita
- Hybribio
- BioPerfectus
- Sansure
- Liferiver
1. How big is the global Infectious Disease Diagnostics market?
2. What is the demand of the global Infectious Disease Diagnostics market?
3. What is the year over year growth of the global Infectious Disease Diagnostics market?
4. What is the total value of the global Infectious Disease Diagnostics market?
5. Who are the Major Players in the global Infectious Disease Diagnostics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Infectious Disease Diagnostics Introduction
1.2 World Infectious Disease Diagnostics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Infectious Disease Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Infectious Disease Diagnostics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.3 China Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.4 Europe Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.5 Japan Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.6 South Korea Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.7 ASEAN Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.8 India Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infectious Disease Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Infectious Disease Diagnostics Consumption Value (2021-2032)
2.2 World Infectious Disease Diagnostics Consumption Value by Region
2.2.1 World Infectious Disease Diagnostics Consumption Value by Region (2021-2026)
2.2.2 World Infectious Disease Diagnostics Consumption Value Forecast by Region (2027-2032)
2.3 United States Infectious Disease Diagnostics Consumption Value (2021-2032)
2.4 China Infectious Disease Diagnostics Consumption Value (2021-2032)
2.5 Europe Infectious Disease Diagnostics Consumption Value (2021-2032)
2.6 Japan Infectious Disease Diagnostics Consumption Value (2021-2032)
2.7 South Korea Infectious Disease Diagnostics Consumption Value (2021-2032)
2.8 ASEAN Infectious Disease Diagnostics Consumption Value (2021-2032)
2.9 India Infectious Disease Diagnostics Consumption Value (2021-2032)
3 WORLD INFECTIOUS DISEASE DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Infectious Disease Diagnostics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Infectious Disease Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Infectious Disease Diagnostics in 2025
3.2.3 Global Concentration Ratios (CR8) for Infectious Disease Diagnostics in 2025
3.3 Infectious Disease Diagnostics Company Evaluation Quadrant
3.4 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Infectious Disease Diagnostics Market: Region Footprint
3.4.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.4.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Infectious Disease Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Infectious Disease Diagnostics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Infectious Disease Diagnostics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Infectious Disease Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Infectious Disease Diagnostics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Infectious Disease Diagnostics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Infectious Disease Diagnostics Companies and Market Share, 2021-2026
4.3.1 United States Based Infectious Disease Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Infectious Disease Diagnostics Revenue, (2021-2026)
4.4 China Based Companies Infectious Disease Diagnostics Revenue and Market Share, 2021-2026
4.4.1 China Based Infectious Disease Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Infectious Disease Diagnostics Revenue, (2021-2026)
4.5 Rest of World Based Infectious Disease Diagnostics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Infectious Disease Diagnostics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Infectious Disease Diagnostics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Sample
5.2.2 Respiratory Sample
5.2.3 Urine Sample
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Infectious Disease Diagnostics Market Size by Type (2021-2026)
5.3.2 World Infectious Disease Diagnostics Market Size by Type (2027-2032)
5.3.3 World Infectious Disease Diagnostics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Infectious Disease Diagnostics Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 Molecular Diagnostics
6.2.2 Immunodiagnostics
6.2.3 Culture & AST
6.2.4 POCT Rapid Tests
6.2.5 Other
6.3 Market Segment by Technology
6.3.1 World Infectious Disease Diagnostics Market Size by Technology (2021-2026)
6.3.2 World Infectious Disease Diagnostics Market Size by Technology (2027-2032)
6.3.3 World Infectious Disease Diagnostics Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY TEST ITEM
7.1 World Infectious Disease Diagnostics Market Size Overview by Test Item: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Test Item
7.2.1 Respiratory Infections
7.2.2 Hepatitis & Blood-borne
7.2.3 Sexually Transmitted Infections
7.2.4 Gastrointestinal Infections
7.2.5 Other
7.3 Market Segment by Test Item
7.3.1 World Infectious Disease Diagnostics Market Size by Test Item (2021-2026)
7.3.2 World Infectious Disease Diagnostics Market Size by Test Item (2027-2032)
7.3.3 World Infectious Disease Diagnostics Market Size Market Share by Test Item (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Infectious Disease Diagnostics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Third-party Independent Laboratory
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Infectious Disease Diagnostics Market Size by Application (2021-2026)
8.3.2 World Infectious Disease Diagnostics Market Size by Application (2027-2032)
8.3.3 World Infectious Disease Diagnostics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 BD
9.1.1 BD Details
9.1.2 BD Major Business
9.1.3 BD Infectious Disease Diagnostics Product and Services
9.1.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 BD Recent Developments/Updates
9.1.6 BD Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher Infectious Disease Diagnostics Product and Services
9.2.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Infectious Disease Diagnostics Product and Services
9.3.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 bioM?rieux
9.4.1 bioM?rieux Details
9.4.2 bioM?rieux Major Business
9.4.3 bioM?rieux Infectious Disease Diagnostics Product and Services
9.4.4 bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 bioM?rieux Recent Developments/Updates
9.4.6 bioM?rieux Competitive Strengths & Weaknesses
9.5 Hologic
9.5.1 Hologic Details
9.5.2 Hologic Major Business
9.5.3 Hologic Infectious Disease Diagnostics Product and Services
9.5.4 Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic Recent Developments/Updates
9.5.6 Hologic Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Details
9.6.2 Thermo Fisher Scientific Major Business
9.6.3 Thermo Fisher Scientific Infectious Disease Diagnostics Product and Services
9.6.4 Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific Recent Developments/Updates
9.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.7 Roche
9.7.1 Roche Details
9.7.2 Roche Major Business
9.7.3 Roche Infectious Disease Diagnostics Product and Services
9.7.4 Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Roche Recent Developments/Updates
9.7.6 Roche Competitive Strengths & Weaknesses
9.8 DiaSorin
9.8.1 DiaSorin Details
9.8.2 DiaSorin Major Business
9.8.3 DiaSorin Infectious Disease Diagnostics Product and Services
9.8.4 DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 DiaSorin Recent Developments/Updates
9.8.6 DiaSorin Competitive Strengths & Weaknesses
9.9 QuidelOrtho
9.9.1 QuidelOrtho Details
9.9.2 QuidelOrtho Major Business
9.9.3 QuidelOrtho Infectious Disease Diagnostics Product and Services
9.9.4 QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 QuidelOrtho Recent Developments/Updates
9.9.6 QuidelOrtho Competitive Strengths & Weaknesses
9.10 Siemens Healthineers
9.10.1 Siemens Healthineers Details
9.10.2 Siemens Healthineers Major Business
9.10.3 Siemens Healthineers Infectious Disease Diagnostics Product and Services
9.10.4 Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Siemens Healthineers Recent Developments/Updates
9.10.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.11 Qiagen
9.11.1 Qiagen Details
9.11.2 Qiagen Major Business
9.11.3 Qiagen Infectious Disease Diagnostics Product and Services
9.11.4 Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Qiagen Recent Developments/Updates
9.11.6 Qiagen Competitive Strengths & Weaknesses
9.12 Bio-Rad
9.12.1 Bio-Rad Details
9.12.2 Bio-Rad Major Business
9.12.3 Bio-Rad Infectious Disease Diagnostics Product and Services
9.12.4 Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bio-Rad Recent Developments/Updates
9.12.6 Bio-Rad Competitive Strengths & Weaknesses
9.13 Wondfo Biotech
9.13.1 Wondfo Biotech Details
9.13.2 Wondfo Biotech Major Business
9.13.3 Wondfo Biotech Infectious Disease Diagnostics Product and Services
9.13.4 Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Wondfo Biotech Recent Developments/Updates
9.13.6 Wondfo Biotech Competitive Strengths & Weaknesses
9.14 Autobio
9.14.1 Autobio Details
9.14.2 Autobio Major Business
9.14.3 Autobio Infectious Disease Diagnostics Product and Services
9.14.4 Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Autobio Recent Developments/Updates
9.14.6 Autobio Competitive Strengths & Weaknesses
9.15 Daan Gene
9.15.1 Daan Gene Details
9.15.2 Daan Gene Major Business
9.15.3 Daan Gene Infectious Disease Diagnostics Product and Services
9.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Daan Gene Recent Developments/Updates
9.15.6 Daan Gene Competitive Strengths & Weaknesses
9.16 Innovita
9.16.1 Innovita Details
9.16.2 Innovita Major Business
9.16.3 Innovita Infectious Disease Diagnostics Product and Services
9.16.4 Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Innovita Recent Developments/Updates
9.16.6 Innovita Competitive Strengths & Weaknesses
9.17 Hybribio
9.17.1 Hybribio Details
9.17.2 Hybribio Major Business
9.17.3 Hybribio Infectious Disease Diagnostics Product and Services
9.17.4 Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Hybribio Recent Developments/Updates
9.17.6 Hybribio Competitive Strengths & Weaknesses
9.18 BioPerfectus
9.18.1 BioPerfectus Details
9.18.2 BioPerfectus Major Business
9.18.3 BioPerfectus Infectious Disease Diagnostics Product and Services
9.18.4 BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 BioPerfectus Recent Developments/Updates
9.18.6 BioPerfectus Competitive Strengths & Weaknesses
9.19 Sansure
9.19.1 Sansure Details
9.19.2 Sansure Major Business
9.19.3 Sansure Infectious Disease Diagnostics Product and Services
9.19.4 Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Sansure Recent Developments/Updates
9.19.6 Sansure Competitive Strengths & Weaknesses
9.20 Liferiver
9.20.1 Liferiver Details
9.20.2 Liferiver Major Business
9.20.3 Liferiver Infectious Disease Diagnostics Product and Services
9.20.4 Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Liferiver Recent Developments/Updates
9.20.6 Liferiver Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Infectious Disease Diagnostics Industry Chain
10.2 Infectious Disease Diagnostics Upstream Analysis
10.3 Infectious Disease Diagnostics Midstream Analysis
10.4 Infectious Disease Diagnostics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Infectious Disease Diagnostics Introduction
1.2 World Infectious Disease Diagnostics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Infectious Disease Diagnostics Total Market by Region (by Headquarter Location)
1.3.1 World Infectious Disease Diagnostics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.3 China Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.4 Europe Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.5 Japan Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.6 South Korea Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.7 ASEAN Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.3.8 India Based Company Infectious Disease Diagnostics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infectious Disease Diagnostics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Infectious Disease Diagnostics Consumption Value (2021-2032)
2.2 World Infectious Disease Diagnostics Consumption Value by Region
2.2.1 World Infectious Disease Diagnostics Consumption Value by Region (2021-2026)
2.2.2 World Infectious Disease Diagnostics Consumption Value Forecast by Region (2027-2032)
2.3 United States Infectious Disease Diagnostics Consumption Value (2021-2032)
2.4 China Infectious Disease Diagnostics Consumption Value (2021-2032)
2.5 Europe Infectious Disease Diagnostics Consumption Value (2021-2032)
2.6 Japan Infectious Disease Diagnostics Consumption Value (2021-2032)
2.7 South Korea Infectious Disease Diagnostics Consumption Value (2021-2032)
2.8 ASEAN Infectious Disease Diagnostics Consumption Value (2021-2032)
2.9 India Infectious Disease Diagnostics Consumption Value (2021-2032)
3 WORLD INFECTIOUS DISEASE DIAGNOSTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Infectious Disease Diagnostics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Infectious Disease Diagnostics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Infectious Disease Diagnostics in 2025
3.2.3 Global Concentration Ratios (CR8) for Infectious Disease Diagnostics in 2025
3.3 Infectious Disease Diagnostics Company Evaluation Quadrant
3.4 Infectious Disease Diagnostics Market: Overall Company Footprint Analysis
3.4.1 Infectious Disease Diagnostics Market: Region Footprint
3.4.2 Infectious Disease Diagnostics Market: Company Product Type Footprint
3.4.3 Infectious Disease Diagnostics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Infectious Disease Diagnostics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Infectious Disease Diagnostics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Infectious Disease Diagnostics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Infectious Disease Diagnostics Consumption Value Comparison
4.2.1 United States VS China: Infectious Disease Diagnostics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Infectious Disease Diagnostics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Infectious Disease Diagnostics Companies and Market Share, 2021-2026
4.3.1 United States Based Infectious Disease Diagnostics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Infectious Disease Diagnostics Revenue, (2021-2026)
4.4 China Based Companies Infectious Disease Diagnostics Revenue and Market Share, 2021-2026
4.4.1 China Based Infectious Disease Diagnostics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Infectious Disease Diagnostics Revenue, (2021-2026)
4.5 Rest of World Based Infectious Disease Diagnostics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Infectious Disease Diagnostics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Infectious Disease Diagnostics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Sample
5.2.2 Respiratory Sample
5.2.3 Urine Sample
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Infectious Disease Diagnostics Market Size by Type (2021-2026)
5.3.2 World Infectious Disease Diagnostics Market Size by Type (2027-2032)
5.3.3 World Infectious Disease Diagnostics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Infectious Disease Diagnostics Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 Molecular Diagnostics
6.2.2 Immunodiagnostics
6.2.3 Culture & AST
6.2.4 POCT Rapid Tests
6.2.5 Other
6.3 Market Segment by Technology
6.3.1 World Infectious Disease Diagnostics Market Size by Technology (2021-2026)
6.3.2 World Infectious Disease Diagnostics Market Size by Technology (2027-2032)
6.3.3 World Infectious Disease Diagnostics Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY TEST ITEM
7.1 World Infectious Disease Diagnostics Market Size Overview by Test Item: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Test Item
7.2.1 Respiratory Infections
7.2.2 Hepatitis & Blood-borne
7.2.3 Sexually Transmitted Infections
7.2.4 Gastrointestinal Infections
7.2.5 Other
7.3 Market Segment by Test Item
7.3.1 World Infectious Disease Diagnostics Market Size by Test Item (2021-2026)
7.3.2 World Infectious Disease Diagnostics Market Size by Test Item (2027-2032)
7.3.3 World Infectious Disease Diagnostics Market Size Market Share by Test Item (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Infectious Disease Diagnostics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Third-party Independent Laboratory
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Infectious Disease Diagnostics Market Size by Application (2021-2026)
8.3.2 World Infectious Disease Diagnostics Market Size by Application (2027-2032)
8.3.3 World Infectious Disease Diagnostics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 BD
9.1.1 BD Details
9.1.2 BD Major Business
9.1.3 BD Infectious Disease Diagnostics Product and Services
9.1.4 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 BD Recent Developments/Updates
9.1.6 BD Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher Infectious Disease Diagnostics Product and Services
9.2.4 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Infectious Disease Diagnostics Product and Services
9.3.4 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 bioM?rieux
9.4.1 bioM?rieux Details
9.4.2 bioM?rieux Major Business
9.4.3 bioM?rieux Infectious Disease Diagnostics Product and Services
9.4.4 bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 bioM?rieux Recent Developments/Updates
9.4.6 bioM?rieux Competitive Strengths & Weaknesses
9.5 Hologic
9.5.1 Hologic Details
9.5.2 Hologic Major Business
9.5.3 Hologic Infectious Disease Diagnostics Product and Services
9.5.4 Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Hologic Recent Developments/Updates
9.5.6 Hologic Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Details
9.6.2 Thermo Fisher Scientific Major Business
9.6.3 Thermo Fisher Scientific Infectious Disease Diagnostics Product and Services
9.6.4 Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific Recent Developments/Updates
9.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.7 Roche
9.7.1 Roche Details
9.7.2 Roche Major Business
9.7.3 Roche Infectious Disease Diagnostics Product and Services
9.7.4 Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Roche Recent Developments/Updates
9.7.6 Roche Competitive Strengths & Weaknesses
9.8 DiaSorin
9.8.1 DiaSorin Details
9.8.2 DiaSorin Major Business
9.8.3 DiaSorin Infectious Disease Diagnostics Product and Services
9.8.4 DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 DiaSorin Recent Developments/Updates
9.8.6 DiaSorin Competitive Strengths & Weaknesses
9.9 QuidelOrtho
9.9.1 QuidelOrtho Details
9.9.2 QuidelOrtho Major Business
9.9.3 QuidelOrtho Infectious Disease Diagnostics Product and Services
9.9.4 QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 QuidelOrtho Recent Developments/Updates
9.9.6 QuidelOrtho Competitive Strengths & Weaknesses
9.10 Siemens Healthineers
9.10.1 Siemens Healthineers Details
9.10.2 Siemens Healthineers Major Business
9.10.3 Siemens Healthineers Infectious Disease Diagnostics Product and Services
9.10.4 Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Siemens Healthineers Recent Developments/Updates
9.10.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.11 Qiagen
9.11.1 Qiagen Details
9.11.2 Qiagen Major Business
9.11.3 Qiagen Infectious Disease Diagnostics Product and Services
9.11.4 Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Qiagen Recent Developments/Updates
9.11.6 Qiagen Competitive Strengths & Weaknesses
9.12 Bio-Rad
9.12.1 Bio-Rad Details
9.12.2 Bio-Rad Major Business
9.12.3 Bio-Rad Infectious Disease Diagnostics Product and Services
9.12.4 Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bio-Rad Recent Developments/Updates
9.12.6 Bio-Rad Competitive Strengths & Weaknesses
9.13 Wondfo Biotech
9.13.1 Wondfo Biotech Details
9.13.2 Wondfo Biotech Major Business
9.13.3 Wondfo Biotech Infectious Disease Diagnostics Product and Services
9.13.4 Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Wondfo Biotech Recent Developments/Updates
9.13.6 Wondfo Biotech Competitive Strengths & Weaknesses
9.14 Autobio
9.14.1 Autobio Details
9.14.2 Autobio Major Business
9.14.3 Autobio Infectious Disease Diagnostics Product and Services
9.14.4 Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Autobio Recent Developments/Updates
9.14.6 Autobio Competitive Strengths & Weaknesses
9.15 Daan Gene
9.15.1 Daan Gene Details
9.15.2 Daan Gene Major Business
9.15.3 Daan Gene Infectious Disease Diagnostics Product and Services
9.15.4 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Daan Gene Recent Developments/Updates
9.15.6 Daan Gene Competitive Strengths & Weaknesses
9.16 Innovita
9.16.1 Innovita Details
9.16.2 Innovita Major Business
9.16.3 Innovita Infectious Disease Diagnostics Product and Services
9.16.4 Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Innovita Recent Developments/Updates
9.16.6 Innovita Competitive Strengths & Weaknesses
9.17 Hybribio
9.17.1 Hybribio Details
9.17.2 Hybribio Major Business
9.17.3 Hybribio Infectious Disease Diagnostics Product and Services
9.17.4 Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Hybribio Recent Developments/Updates
9.17.6 Hybribio Competitive Strengths & Weaknesses
9.18 BioPerfectus
9.18.1 BioPerfectus Details
9.18.2 BioPerfectus Major Business
9.18.3 BioPerfectus Infectious Disease Diagnostics Product and Services
9.18.4 BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 BioPerfectus Recent Developments/Updates
9.18.6 BioPerfectus Competitive Strengths & Weaknesses
9.19 Sansure
9.19.1 Sansure Details
9.19.2 Sansure Major Business
9.19.3 Sansure Infectious Disease Diagnostics Product and Services
9.19.4 Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Sansure Recent Developments/Updates
9.19.6 Sansure Competitive Strengths & Weaknesses
9.20 Liferiver
9.20.1 Liferiver Details
9.20.2 Liferiver Major Business
9.20.3 Liferiver Infectious Disease Diagnostics Product and Services
9.20.4 Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Liferiver Recent Developments/Updates
9.20.6 Liferiver Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Infectious Disease Diagnostics Industry Chain
10.2 Infectious Disease Diagnostics Upstream Analysis
10.3 Infectious Disease Diagnostics Midstream Analysis
10.4 Infectious Disease Diagnostics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Infectious Disease Diagnostics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Infectious Disease Diagnostics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Infectious Disease Diagnostics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Infectious Disease Diagnostics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Infectious Disease Diagnostics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Infectious Disease Diagnostics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Infectious Disease Diagnostics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Infectious Disease Diagnostics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Infectious Disease Diagnostics Players in 2025
Table 12. World Infectious Disease Diagnostics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Infectious Disease Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Infectious Disease Diagnostics Players
Table 15. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 16. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 17. Infectious Disease Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Infectious Disease Diagnostics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Infectious Disease Diagnostics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Infectious Disease Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Infectious Disease Diagnostics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 23. China Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Infectious Disease Diagnostics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Infectious Disease Diagnostics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 29. World Infectious Disease Diagnostics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Infectious Disease Diagnostics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Infectious Disease Diagnostics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Infectious Disease Diagnostics Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Infectious Disease Diagnostics Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Infectious Disease Diagnostics Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Infectious Disease Diagnostics Market Size by Test Item, (USD Million), 2021 & 2025 & 2032
Table 36. World Infectious Disease Diagnostics Market Size Value by Test Item (2021-2026) & (USD Million)
Table 37. World Infectious Disease Diagnostics Market Size by Test Item (2027-2032) & (USD Million)
Table 38. World Infectious Disease Diagnostics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Infectious Disease Diagnostics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Infectious Disease Diagnostics Market Size by Application (2027-2032) & (USD Million)
Table 41. BD Basic Information, Manufacturing Base and Competitors
Table 42. BD Major Business
Table 43. BD Infectious Disease Diagnostics Product and Services
Table 44. BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. BD Recent Developments/Updates
Table 46. BD Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher Infectious Disease Diagnostics Product and Services
Table 50. Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Infectious Disease Diagnostics Product and Services
Table 56. Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. bioM?rieux Basic Information, Manufacturing Base and Competitors
Table 60. bioM?rieux Major Business
Table 61. bioM?rieux Infectious Disease Diagnostics Product and Services
Table 62. bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. bioM?rieux Recent Developments/Updates
Table 64. bioM?rieux Competitive Strengths & Weaknesses
Table 65. Hologic Basic Information, Manufacturing Base and Competitors
Table 66. Hologic Major Business
Table 67. Hologic Infectious Disease Diagnostics Product and Services
Table 68. Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic Recent Developments/Updates
Table 70. Hologic Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific Infectious Disease Diagnostics Product and Services
Table 74. Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Roche Basic Information, Manufacturing Base and Competitors
Table 78. Roche Major Business
Table 79. Roche Infectious Disease Diagnostics Product and Services
Table 80. Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Roche Recent Developments/Updates
Table 82. Roche Competitive Strengths & Weaknesses
Table 83. DiaSorin Basic Information, Manufacturing Base and Competitors
Table 84. DiaSorin Major Business
Table 85. DiaSorin Infectious Disease Diagnostics Product and Services
Table 86. DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. DiaSorin Recent Developments/Updates
Table 88. DiaSorin Competitive Strengths & Weaknesses
Table 89. QuidelOrtho Basic Information, Manufacturing Base and Competitors
Table 90. QuidelOrtho Major Business
Table 91. QuidelOrtho Infectious Disease Diagnostics Product and Services
Table 92. QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. QuidelOrtho Recent Developments/Updates
Table 94. QuidelOrtho Competitive Strengths & Weaknesses
Table 95. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 96. Siemens Healthineers Major Business
Table 97. Siemens Healthineers Infectious Disease Diagnostics Product and Services
Table 98. Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Siemens Healthineers Recent Developments/Updates
Table 100. Siemens Healthineers Competitive Strengths & Weaknesses
Table 101. Qiagen Basic Information, Manufacturing Base and Competitors
Table 102. Qiagen Major Business
Table 103. Qiagen Infectious Disease Diagnostics Product and Services
Table 104. Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Qiagen Recent Developments/Updates
Table 106. Qiagen Competitive Strengths & Weaknesses
Table 107. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 108. Bio-Rad Major Business
Table 109. Bio-Rad Infectious Disease Diagnostics Product and Services
Table 110. Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bio-Rad Recent Developments/Updates
Table 112. Bio-Rad Competitive Strengths & Weaknesses
Table 113. Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 114. Wondfo Biotech Major Business
Table 115. Wondfo Biotech Infectious Disease Diagnostics Product and Services
Table 116. Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Wondfo Biotech Recent Developments/Updates
Table 118. Wondfo Biotech Competitive Strengths & Weaknesses
Table 119. Autobio Basic Information, Manufacturing Base and Competitors
Table 120. Autobio Major Business
Table 121. Autobio Infectious Disease Diagnostics Product and Services
Table 122. Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Autobio Recent Developments/Updates
Table 124. Autobio Competitive Strengths & Weaknesses
Table 125. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 126. Daan Gene Major Business
Table 127. Daan Gene Infectious Disease Diagnostics Product and Services
Table 128. Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Daan Gene Recent Developments/Updates
Table 130. Daan Gene Competitive Strengths & Weaknesses
Table 131. Innovita Basic Information, Manufacturing Base and Competitors
Table 132. Innovita Major Business
Table 133. Innovita Infectious Disease Diagnostics Product and Services
Table 134. Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Innovita Recent Developments/Updates
Table 136. Innovita Competitive Strengths & Weaknesses
Table 137. Hybribio Basic Information, Manufacturing Base and Competitors
Table 138. Hybribio Major Business
Table 139. Hybribio Infectious Disease Diagnostics Product and Services
Table 140. Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Hybribio Recent Developments/Updates
Table 142. Hybribio Competitive Strengths & Weaknesses
Table 143. BioPerfectus Basic Information, Manufacturing Base and Competitors
Table 144. BioPerfectus Major Business
Table 145. BioPerfectus Infectious Disease Diagnostics Product and Services
Table 146. BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. BioPerfectus Recent Developments/Updates
Table 148. BioPerfectus Competitive Strengths & Weaknesses
Table 149. Sansure Basic Information, Manufacturing Base and Competitors
Table 150. Sansure Major Business
Table 151. Sansure Infectious Disease Diagnostics Product and Services
Table 152. Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Sansure Recent Developments/Updates
Table 154. Sansure Competitive Strengths & Weaknesses
Table 155. Liferiver Basic Information, Manufacturing Base and Competitors
Table 156. Liferiver Major Business
Table 157. Liferiver Infectious Disease Diagnostics Product and Services
Table 158. Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Liferiver Recent Developments/Updates
Table 160. Liferiver Competitive Strengths & Weaknesses
Table 161. Global Key Players of Infectious Disease Diagnostics Upstream (Raw Materials)
Table 162. Global Infectious Disease Diagnostics Typical Customers
Table 1. World Infectious Disease Diagnostics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Infectious Disease Diagnostics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Infectious Disease Diagnostics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Infectious Disease Diagnostics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Infectious Disease Diagnostics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Infectious Disease Diagnostics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Infectious Disease Diagnostics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Infectious Disease Diagnostics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Infectious Disease Diagnostics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Infectious Disease Diagnostics Players in 2025
Table 12. World Infectious Disease Diagnostics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Infectious Disease Diagnostics Company Evaluation Quadrant
Table 14. Head Office of Key Infectious Disease Diagnostics Players
Table 15. Infectious Disease Diagnostics Market: Company Product Type Footprint
Table 16. Infectious Disease Diagnostics Market: Company Product Application Footprint
Table 17. Infectious Disease Diagnostics Mergers & Acquisitions Activity
Table 18. United States VS China Infectious Disease Diagnostics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Infectious Disease Diagnostics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Infectious Disease Diagnostics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Infectious Disease Diagnostics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 23. China Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Infectious Disease Diagnostics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Infectious Disease Diagnostics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Infectious Disease Diagnostics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Infectious Disease Diagnostics Revenue Market Share (2021-2026)
Table 29. World Infectious Disease Diagnostics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Infectious Disease Diagnostics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Infectious Disease Diagnostics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Infectious Disease Diagnostics Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Infectious Disease Diagnostics Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Infectious Disease Diagnostics Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Infectious Disease Diagnostics Market Size by Test Item, (USD Million), 2021 & 2025 & 2032
Table 36. World Infectious Disease Diagnostics Market Size Value by Test Item (2021-2026) & (USD Million)
Table 37. World Infectious Disease Diagnostics Market Size by Test Item (2027-2032) & (USD Million)
Table 38. World Infectious Disease Diagnostics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Infectious Disease Diagnostics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Infectious Disease Diagnostics Market Size by Application (2027-2032) & (USD Million)
Table 41. BD Basic Information, Manufacturing Base and Competitors
Table 42. BD Major Business
Table 43. BD Infectious Disease Diagnostics Product and Services
Table 44. BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. BD Recent Developments/Updates
Table 46. BD Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher Infectious Disease Diagnostics Product and Services
Table 50. Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Infectious Disease Diagnostics Product and Services
Table 56. Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. bioM?rieux Basic Information, Manufacturing Base and Competitors
Table 60. bioM?rieux Major Business
Table 61. bioM?rieux Infectious Disease Diagnostics Product and Services
Table 62. bioM?rieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. bioM?rieux Recent Developments/Updates
Table 64. bioM?rieux Competitive Strengths & Weaknesses
Table 65. Hologic Basic Information, Manufacturing Base and Competitors
Table 66. Hologic Major Business
Table 67. Hologic Infectious Disease Diagnostics Product and Services
Table 68. Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Hologic Recent Developments/Updates
Table 70. Hologic Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific Infectious Disease Diagnostics Product and Services
Table 74. Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Roche Basic Information, Manufacturing Base and Competitors
Table 78. Roche Major Business
Table 79. Roche Infectious Disease Diagnostics Product and Services
Table 80. Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Roche Recent Developments/Updates
Table 82. Roche Competitive Strengths & Weaknesses
Table 83. DiaSorin Basic Information, Manufacturing Base and Competitors
Table 84. DiaSorin Major Business
Table 85. DiaSorin Infectious Disease Diagnostics Product and Services
Table 86. DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. DiaSorin Recent Developments/Updates
Table 88. DiaSorin Competitive Strengths & Weaknesses
Table 89. QuidelOrtho Basic Information, Manufacturing Base and Competitors
Table 90. QuidelOrtho Major Business
Table 91. QuidelOrtho Infectious Disease Diagnostics Product and Services
Table 92. QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. QuidelOrtho Recent Developments/Updates
Table 94. QuidelOrtho Competitive Strengths & Weaknesses
Table 95. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 96. Siemens Healthineers Major Business
Table 97. Siemens Healthineers Infectious Disease Diagnostics Product and Services
Table 98. Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Siemens Healthineers Recent Developments/Updates
Table 100. Siemens Healthineers Competitive Strengths & Weaknesses
Table 101. Qiagen Basic Information, Manufacturing Base and Competitors
Table 102. Qiagen Major Business
Table 103. Qiagen Infectious Disease Diagnostics Product and Services
Table 104. Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Qiagen Recent Developments/Updates
Table 106. Qiagen Competitive Strengths & Weaknesses
Table 107. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 108. Bio-Rad Major Business
Table 109. Bio-Rad Infectious Disease Diagnostics Product and Services
Table 110. Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bio-Rad Recent Developments/Updates
Table 112. Bio-Rad Competitive Strengths & Weaknesses
Table 113. Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 114. Wondfo Biotech Major Business
Table 115. Wondfo Biotech Infectious Disease Diagnostics Product and Services
Table 116. Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Wondfo Biotech Recent Developments/Updates
Table 118. Wondfo Biotech Competitive Strengths & Weaknesses
Table 119. Autobio Basic Information, Manufacturing Base and Competitors
Table 120. Autobio Major Business
Table 121. Autobio Infectious Disease Diagnostics Product and Services
Table 122. Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Autobio Recent Developments/Updates
Table 124. Autobio Competitive Strengths & Weaknesses
Table 125. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 126. Daan Gene Major Business
Table 127. Daan Gene Infectious Disease Diagnostics Product and Services
Table 128. Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Daan Gene Recent Developments/Updates
Table 130. Daan Gene Competitive Strengths & Weaknesses
Table 131. Innovita Basic Information, Manufacturing Base and Competitors
Table 132. Innovita Major Business
Table 133. Innovita Infectious Disease Diagnostics Product and Services
Table 134. Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Innovita Recent Developments/Updates
Table 136. Innovita Competitive Strengths & Weaknesses
Table 137. Hybribio Basic Information, Manufacturing Base and Competitors
Table 138. Hybribio Major Business
Table 139. Hybribio Infectious Disease Diagnostics Product and Services
Table 140. Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Hybribio Recent Developments/Updates
Table 142. Hybribio Competitive Strengths & Weaknesses
Table 143. BioPerfectus Basic Information, Manufacturing Base and Competitors
Table 144. BioPerfectus Major Business
Table 145. BioPerfectus Infectious Disease Diagnostics Product and Services
Table 146. BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. BioPerfectus Recent Developments/Updates
Table 148. BioPerfectus Competitive Strengths & Weaknesses
Table 149. Sansure Basic Information, Manufacturing Base and Competitors
Table 150. Sansure Major Business
Table 151. Sansure Infectious Disease Diagnostics Product and Services
Table 152. Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Sansure Recent Developments/Updates
Table 154. Sansure Competitive Strengths & Weaknesses
Table 155. Liferiver Basic Information, Manufacturing Base and Competitors
Table 156. Liferiver Major Business
Table 157. Liferiver Infectious Disease Diagnostics Product and Services
Table 158. Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Liferiver Recent Developments/Updates
Table 160. Liferiver Competitive Strengths & Weaknesses
Table 161. Global Key Players of Infectious Disease Diagnostics Upstream (Raw Materials)
Table 162. Global Infectious Disease Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. World Infectious Disease Diagnostics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Infectious Disease Diagnostics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Infectious Disease Diagnostics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Infectious Disease Diagnostics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 13. Infectious Disease Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Infectious Disease Diagnostics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Infectious Disease Diagnostics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Infectious Disease Diagnostics Markets in 2025
Figure 27. United States VS China: Infectious Disease Diagnostics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Infectious Disease Diagnostics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Infectious Disease Diagnostics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Infectious Disease Diagnostics Market Size Market Share by Type in 2025
Figure 31. Blood Sample
Figure 32. Respiratory Sample
Figure 33. Urine Sample
Figure 34. Other
Figure 35. World Infectious Disease Diagnostics Market Size Market Share by Type (2021-2032)
Figure 36. World Infectious Disease Diagnostics Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World Infectious Disease Diagnostics Market Size Market Share by Technology in 2025
Figure 38. Molecular Diagnostics
Figure 39. Immunodiagnostics
Figure 40. Culture & AST
Figure 41. POCT Rapid Tests
Figure 42. Other
Figure 43. World Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2032)
Figure 44. World Infectious Disease Diagnostics Market Size by Test Item, (USD Million), 2021 & 2025 & 2032
Figure 45. World Infectious Disease Diagnostics Market Size Market Share by Test Item in 2025
Figure 46. Respiratory Infections
Figure 47. Hepatitis & Blood-borne
Figure 48. Sexually Transmitted Infections
Figure 49. Gastrointestinal Infections
Figure 50. Other
Figure 51. World Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2032)
Figure 52. World Infectious Disease Diagnostics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Infectious Disease Diagnostics Market Size Market Share by Application in 2025
Figure 54. Public Hospitals
Figure 55. Third-party Independent Laboratory
Figure 56. Other
Figure 57. World Infectious Disease Diagnostics Market Size Market Share by Application (2021-2032)
Figure 58. Infectious Disease Diagnostics Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. Infectious Disease Diagnostics Picture
Figure 2. World Infectious Disease Diagnostics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Infectious Disease Diagnostics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Infectious Disease Diagnostics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Infectious Disease Diagnostics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Infectious Disease Diagnostics Revenue (2021-2032) & (USD Million)
Figure 13. Infectious Disease Diagnostics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Infectious Disease Diagnostics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Infectious Disease Diagnostics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Infectious Disease Diagnostics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Infectious Disease Diagnostics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Infectious Disease Diagnostics Markets in 2025
Figure 27. United States VS China: Infectious Disease Diagnostics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Infectious Disease Diagnostics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Infectious Disease Diagnostics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Infectious Disease Diagnostics Market Size Market Share by Type in 2025
Figure 31. Blood Sample
Figure 32. Respiratory Sample
Figure 33. Urine Sample
Figure 34. Other
Figure 35. World Infectious Disease Diagnostics Market Size Market Share by Type (2021-2032)
Figure 36. World Infectious Disease Diagnostics Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 37. World Infectious Disease Diagnostics Market Size Market Share by Technology in 2025
Figure 38. Molecular Diagnostics
Figure 39. Immunodiagnostics
Figure 40. Culture & AST
Figure 41. POCT Rapid Tests
Figure 42. Other
Figure 43. World Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2032)
Figure 44. World Infectious Disease Diagnostics Market Size by Test Item, (USD Million), 2021 & 2025 & 2032
Figure 45. World Infectious Disease Diagnostics Market Size Market Share by Test Item in 2025
Figure 46. Respiratory Infections
Figure 47. Hepatitis & Blood-borne
Figure 48. Sexually Transmitted Infections
Figure 49. Gastrointestinal Infections
Figure 50. Other
Figure 51. World Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2032)
Figure 52. World Infectious Disease Diagnostics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Infectious Disease Diagnostics Market Size Market Share by Application in 2025
Figure 54. Public Hospitals
Figure 55. Third-party Independent Laboratory
Figure 56. Other
Figure 57. World Infectious Disease Diagnostics Market Size Market Share by Application (2021-2032)
Figure 58. Infectious Disease Diagnostics Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
